GlucoBeamTM

The world's first touch glucose monitoring technology

GlucoBeam is not yet cleared for market by health regulators

See it - Believe it

Our Touch Glucose Monitoring (TGM™) Technology has been tested with more than 600 patients in clinical- and home settings, proving a stable state-of-the-art performance.

Play Video

GlucoBeam Highlights

How GlucoBeam works

Measuring
Simply touch the device and a beam of light shines through the skin.
Analyzing
Light scattered from the skin is collected and processed using artificial intelligence (AI).
how-GlucoBeam-works-3
Glucose measurement is displayed within a few minutes.

Device Roadmap

*System not yet approved in the US

2009

First system to measure glucose non-invasively *

2009

Critical Depth patent granted

2019

First iteration of GlucoBeam *

2021

Clinical testing totaling 600+ participants

Future

FDA clearance of GlucoBeam

Future

Commercialization of GlucoBeam in the U.S.

Future

Advanced algorithm for improved accuracy

Future

Hand-held form factor

Future

Wearable form factor

Customizable

to fit partner requirements​

Our technology offers new, vital information to individuals that are unwilling to use existing measurement devices because of pain, inconvenience and stigma involved. TGM will offer a unique position for Digital health partners and employers in the fast-growing digital health sector and enable them to establish a brand-new access point to vital health information.